All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
Search results for “heart failure”
Show results per page.
Showing 26–50 of 50 results.
Type 2 Diabetes Pathway to Remission Programme
https://northeast.devonformularyguidance.nhs.uk/referral-guidance/northern-locality/endocrinology/type-2-diabetes-path-to-remission-programme 10.1.4 Gout and cytotoxic-induced hyperuricaemia
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/10-musculoskeletal-joint-diseases/10-1-rheumatic-diseases-and-gout/10-1-4-gout-and-cytotoxic-induced-hyperuricaemia 10.1.3 Drugs that suppress the rheumatic disease process
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/10-musculoskeletal-joint-diseases/10-1-rheumatic-diseases-and-gout/10-1-3-drugs-suppress-rheumatic-disease 2.8.2 Oral anticoagulants
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-8-anticoagulants-and-protamine/2-8-2-oral-anticoagulants 2.6.2 Calcium-channel blockers
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-6-nitrates-ccbs-and-other-antianginal/2-6-2-calcium-channel-blockers 2.5.5 Drugs affecting the renin-angiotensin system
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-5-hypertension-and-heart-failure/2-5-5-drugs-affecting-the-renin-angiotensin-system 2.5.1 Vasodilator antihypertensive drugs
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-5-hypertension-and-heart-failure/2-5-1-vasodilator-antihypertensive-drugs 2.2.3 Potassium-sparing diuretics and aldosterone antagonists
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-2-diuretics/2-2-3-potassium-sparing-and-aldosterone-antagonists 3.1.2 Antimuscarinic bronchodilators
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/3-respiratory/3-1-bronchodilators/3-1-2-antimuscarinic-bronchodilators 3.1.4 Combination inhalers
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/3-respiratory/3-1-bronchodilators/3-1-4-combination-inhalers 2.6.3 Other antianginal drugs
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-6-nitrates-ccbs-and-other-antianginal/2-6-3-other-antianginal-drugs 2.1 Positive inotropic drugs
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-1-positive-inotropic-drugs 2.4 Beta-adrenoceptor blocking drugs
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-4-beta-adrenoceptor-blocking-drugs 4.3.3 Selective serotonin re-uptake inhibitors
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/4-central-nervous-system/4-3-antidepressant-drugs/4-3-3-ssri 10.1.1 Non-steroidal anti-inflammatory drugs (NSAIDs)
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/10-musculoskeletal-joint-diseases/10-1-rheumatic-diseases-and-gout/10-1-1-nsaids 2.2.1 Thiazides and related diuretics
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-2-diuretics/2-2-1-thiazides-and-related-diuretics 9.2.1 Oral preparations for fluid and electrolyte imbalance
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/9-blood-and-nutrition/9-2-fluid-and-electrolytes/9-2-1-oral-preparations-for-fluid-and-electrolyte-imbalance 8.5.9 Multikinase inhibitors
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-5-targeted-antineoplastics/8-5-9-multikinase-inhibitors 6.1.2 Antidiabetic drugs
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/6-endocrine/6-1-drugs-used-in-diabetes/6-1-2-antidiabetic-drugs 5.3.6 nMABs and other antiviral drugs
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/5-infections/5-3-antiviral-drugs/5-3-6-other-antiviral-drugs 4.7.4 Antimigraine drugs
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/4-central-nervous-system/4-7-analgesics/4-7-4-antimigraine-drugs 4.7.1 Non-opioid analgesics and compound analgesic preparations
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/4-central-nervous-system/4-7-analgesics/4-7-1-non-opioid-analgesics-and-compound-analgesic 4.6 Drugs used in nausea and vertigo
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/4-central-nervous-system/4-6-drugs-used-in-nausea-and-vertigo 1.2 Antispasmodics and other drugs altering gut motility
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/1-gastrointestinal/1-2-antispasmodics 5.1.5 Macrolides
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/5-infections/5-1-antibacterial-drugs/5-1-5-macrolides
https://northeast.devonformularyguidance.nhs.uk/referral-guidance/northern-locality/endocrinology/type-2-diabetes-path-to-remission-programme 10.1.4 Gout and cytotoxic-induced hyperuricaemia
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/10-musculoskeletal-joint-diseases/10-1-rheumatic-diseases-and-gout/10-1-4-gout-and-cytotoxic-induced-hyperuricaemia 10.1.3 Drugs that suppress the rheumatic disease process
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/10-musculoskeletal-joint-diseases/10-1-rheumatic-diseases-and-gout/10-1-3-drugs-suppress-rheumatic-disease 2.8.2 Oral anticoagulants
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-8-anticoagulants-and-protamine/2-8-2-oral-anticoagulants 2.6.2 Calcium-channel blockers
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-6-nitrates-ccbs-and-other-antianginal/2-6-2-calcium-channel-blockers 2.5.5 Drugs affecting the renin-angiotensin system
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-5-hypertension-and-heart-failure/2-5-5-drugs-affecting-the-renin-angiotensin-system 2.5.1 Vasodilator antihypertensive drugs
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-5-hypertension-and-heart-failure/2-5-1-vasodilator-antihypertensive-drugs 2.2.3 Potassium-sparing diuretics and aldosterone antagonists
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-2-diuretics/2-2-3-potassium-sparing-and-aldosterone-antagonists 3.1.2 Antimuscarinic bronchodilators
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/3-respiratory/3-1-bronchodilators/3-1-2-antimuscarinic-bronchodilators 3.1.4 Combination inhalers
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/3-respiratory/3-1-bronchodilators/3-1-4-combination-inhalers 2.6.3 Other antianginal drugs
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-6-nitrates-ccbs-and-other-antianginal/2-6-3-other-antianginal-drugs 2.1 Positive inotropic drugs
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-1-positive-inotropic-drugs 2.4 Beta-adrenoceptor blocking drugs
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-4-beta-adrenoceptor-blocking-drugs 4.3.3 Selective serotonin re-uptake inhibitors
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/4-central-nervous-system/4-3-antidepressant-drugs/4-3-3-ssri 10.1.1 Non-steroidal anti-inflammatory drugs (NSAIDs)
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/10-musculoskeletal-joint-diseases/10-1-rheumatic-diseases-and-gout/10-1-1-nsaids 2.2.1 Thiazides and related diuretics
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/2-cardiovascular/2-2-diuretics/2-2-1-thiazides-and-related-diuretics 9.2.1 Oral preparations for fluid and electrolyte imbalance
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/9-blood-and-nutrition/9-2-fluid-and-electrolytes/9-2-1-oral-preparations-for-fluid-and-electrolyte-imbalance 8.5.9 Multikinase inhibitors
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-5-targeted-antineoplastics/8-5-9-multikinase-inhibitors 6.1.2 Antidiabetic drugs
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/6-endocrine/6-1-drugs-used-in-diabetes/6-1-2-antidiabetic-drugs 5.3.6 nMABs and other antiviral drugs
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/5-infections/5-3-antiviral-drugs/5-3-6-other-antiviral-drugs 4.7.4 Antimigraine drugs
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/4-central-nervous-system/4-7-analgesics/4-7-4-antimigraine-drugs 4.7.1 Non-opioid analgesics and compound analgesic preparations
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/4-central-nervous-system/4-7-analgesics/4-7-1-non-opioid-analgesics-and-compound-analgesic 4.6 Drugs used in nausea and vertigo
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/4-central-nervous-system/4-6-drugs-used-in-nausea-and-vertigo 1.2 Antispasmodics and other drugs altering gut motility
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/1-gastrointestinal/1-2-antispasmodics 5.1.5 Macrolides
https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/5-infections/5-1-antibacterial-drugs/5-1-5-macrolides
